Polymorphisms in the genes for two members of the thioredoxin reductase family of selenoproteins (TXNRD1 and TXNRD2) and Selenoprotein K (SELENOK) associated with prostate cancer risk only when selenium status was also considered [101]. This evidence concerns the gene SELENOK and prostate carcinoma.